Skip to content

Opening book details…

About this Medicine article

A phase I study evaluating ibritumomab tiuxetan (Zevalin ® ) in combination with bortezomib (Velcade ® ) in relapsed/refractory mantle cell and low grade B-cell non-Hodgkin lymphoma by Beaven, Anne W.; Shea, Thomas C.; Moore, Dominic T.; Feldman, Tatyana; Ivanova, Anastasia; Ferraro, Madlyn; Ford, Peggy; Smith, Judith; Goy, Andre is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Beaven, Anne W.; Shea, Thomas C.; Moore, Dominic T.; Feldman, Tatyana; Ivanova, Anastasia; Ferraro, Madlyn; Ford, Peggy; Smith, Judith; Goy, Andre
Publisher
Informa plc; Informa UK (Taylor & Francis); Taylor & Francis; Informa UK Limited (ISSN 1042-8194)
Published
2012
Language
EN
Field
Medicine (Health Sciences)

More by Beaven, Anne W.; Shea, Thomas C.; Moore, Dominic T.; Feldman, Tatyana; Ivanova, Anastasia; Ferraro, Madlyn; Ford, Peggy; Smith, Judith; Goy, Andre

Browse all works by Beaven, Anne W.; Shea, Thomas C.; Moore, Dominic T.; Feldman, Tatyana; Ivanova, Anastasia; Ferraro, Madlyn; Ford, Peggy; Smith, Judith; Goy, Andre